Bone-conserving hip replacement option good choice for younger patients

November 07, 2000

A study published in September's British Journal of Bone and Joint Surgery concludes that a hip replacement device developed at Mayo Clinic is successful in conserving bone, making it an attractive choice for younger patients.

The study followed 162 consecutive replacements using the conservative device at Mayo Clinic. Before surgery 53 percent of the patients, whose average age was 50.8 years, walked with a moderate or severe limp, and 91 percent reported moderate or severe pain. At a mean of 6.2 years after replacement, 95 percent had no limp or only a slight one, and 91 percent felt no or slight pain. None of the patients had significant thigh pain.

"When patients receive a total hip replacement in their 70s, that joint is likely to last the rest of their lives," says Bernard F. Morrey, M.D., a Mayo Clinic orthopedic surgeon who designed the Mayo Conservative Hip™and authored the study. "Patients in their 50s are much more likely to live long enough to need a second replacement, or revision, of the same joint. For these people, a bone-conserving option is desirable so that the subsequent revision can be done with conventional devices.

The 98 percent mechanical stability of this device and the relative absence of pain suggest that it is a good first choice for younger, more active patients."
Source: A Conservative Femoral Replacement for Total Hip Arthroplasty. British Journal of Bone and Joint Surgery. Sept. 2000. 952-958.

Mayo Clinic

Related Mayo Clinic Articles from Brightsurf:

Mayo Clinic-led study links obesity with pancreatitis
A study by researchers at Mayo Clinic in Arizona published in the The Journal of Clinical Investigation has found that obesity is not only implicated in chronic diseases such as diabetes, but also in sudden-onset diseases such as pancreatitis.

Mayo Clinic researchers clarify how cells defend themselves from viruses
A protein known to help cells defend against infection also regulates the form and function of mitochondria, according to a new paper in Nature Communications.

Mayo Clinic study looks at changes in outcomes for coronary revascularization
The most common type of heart disease -- coronary artery disease -- affects 6.7% of adults and accounts for 20% of 2 in 10 deaths of adults under age 65.

Mayo Clinic researchers review modern cases of leprosy
Leprosy has a history that has spanned centuries and societies across the globe.

Kidney stones on the rise, Mayo Clinic study finds
Kidney stones are a painful health condition, often requiring multiple procedures at great discomfort to the patient.

Mayo Clinic researchers demonstrate value of second opinions
Many patients come to Mayo Clinic for a second opinion or diagnosis confirmation before treatment for a complex condition.

Mayo Clinic researchers clarify chemo resistance, and perhaps a new therapy
Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool.

Mayo Clinic researchers identify therapy
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma.

Mayo Clinic researchers uncover new agents
Mayo Clinic researchers have uncovered three new agents to add to the emerging repertoire of drugs that aim to delay the onset of aging by targeting senescent cells -- cells that contribute to frailty and other age-related conditions.

Mayo Clinic: Reversing physician burnout, using nine strategies to promote well-being
Researchers at Mayo Clinic have been documenting the rise and costs of physician burnout for more than a decade.

Read More: Mayo Clinic News and Mayo Clinic Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to